Inherent inaccuracies and potential utility of race/ethnicity labeling in the treatment of hypertension

Barry J Materson, Eileen M. Bernal

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The use of racial/ethnic labeling for any purpose is fraught with substantial emotional, social and political consequences even when used for demographic studies or census. In addition to the very real historical conflicts associated with slavery in the Americas and various social classification systems elsewhere, such labeling has been shown by the use of ancestral identification markers to be inaccurate in many cases. Even geographic labeling, such as East Asians, ignores the marked heterogeneity of East Asians. The use of race alone to determine selection of initial antihypertensive therapy is a very limited approach. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents has demonstrated, however, that the use of age and race together may be a useful paradigm for predicting response to a single antihypertensive drug. Furthermore, individuals from populations who consume high levels of sodium and lower levels of potassium may respond better to diuretics and calcium antagonists. Other populations may be more susceptible to angioedema or cough related to the use of angiotensin-converting enzyme inhibitors. Such information may be useful for the selection or avoidance of certain medications. No patient should ever be denied indicated treatment with a drug or drug class because of race or ethnicity.

Original languageEnglish
Pages (from-to)291-294
Number of pages4
JournalJournal of the American Society of Hypertension
Volume3
Issue number5
DOIs
StatePublished - Sep 1 2009

Fingerprint

Antihypertensive Agents
Hypertension
Slavery
Angioedema
Veterans
Censuses
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Cough
Pharmaceutical Preparations
Population
Potassium
Therapeutics
Sodium
Demography
Calcium

Keywords

  • African-American
  • ancestry-informative markers
  • blood pressure
  • Hispanic

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Inherent inaccuracies and potential utility of race/ethnicity labeling in the treatment of hypertension. / Materson, Barry J; Bernal, Eileen M.

In: Journal of the American Society of Hypertension, Vol. 3, No. 5, 01.09.2009, p. 291-294.

Research output: Contribution to journalArticle

@article{7ab3b1b8f6cd4549bbee817d78baeac0,
title = "Inherent inaccuracies and potential utility of race/ethnicity labeling in the treatment of hypertension",
abstract = "The use of racial/ethnic labeling for any purpose is fraught with substantial emotional, social and political consequences even when used for demographic studies or census. In addition to the very real historical conflicts associated with slavery in the Americas and various social classification systems elsewhere, such labeling has been shown by the use of ancestral identification markers to be inaccurate in many cases. Even geographic labeling, such as East Asians, ignores the marked heterogeneity of East Asians. The use of race alone to determine selection of initial antihypertensive therapy is a very limited approach. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents has demonstrated, however, that the use of age and race together may be a useful paradigm for predicting response to a single antihypertensive drug. Furthermore, individuals from populations who consume high levels of sodium and lower levels of potassium may respond better to diuretics and calcium antagonists. Other populations may be more susceptible to angioedema or cough related to the use of angiotensin-converting enzyme inhibitors. Such information may be useful for the selection or avoidance of certain medications. No patient should ever be denied indicated treatment with a drug or drug class because of race or ethnicity.",
keywords = "African-American, ancestry-informative markers, blood pressure, Hispanic",
author = "Materson, {Barry J} and Bernal, {Eileen M.}",
year = "2009",
month = "9",
day = "1",
doi = "10.1016/j.jash.2009.08.001",
language = "English",
volume = "3",
pages = "291--294",
journal = "Journal of the American Society of Hypertension",
issn = "1933-1711",
publisher = "Elsevier Ireland Ltd",
number = "5",

}

TY - JOUR

T1 - Inherent inaccuracies and potential utility of race/ethnicity labeling in the treatment of hypertension

AU - Materson, Barry J

AU - Bernal, Eileen M.

PY - 2009/9/1

Y1 - 2009/9/1

N2 - The use of racial/ethnic labeling for any purpose is fraught with substantial emotional, social and political consequences even when used for demographic studies or census. In addition to the very real historical conflicts associated with slavery in the Americas and various social classification systems elsewhere, such labeling has been shown by the use of ancestral identification markers to be inaccurate in many cases. Even geographic labeling, such as East Asians, ignores the marked heterogeneity of East Asians. The use of race alone to determine selection of initial antihypertensive therapy is a very limited approach. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents has demonstrated, however, that the use of age and race together may be a useful paradigm for predicting response to a single antihypertensive drug. Furthermore, individuals from populations who consume high levels of sodium and lower levels of potassium may respond better to diuretics and calcium antagonists. Other populations may be more susceptible to angioedema or cough related to the use of angiotensin-converting enzyme inhibitors. Such information may be useful for the selection or avoidance of certain medications. No patient should ever be denied indicated treatment with a drug or drug class because of race or ethnicity.

AB - The use of racial/ethnic labeling for any purpose is fraught with substantial emotional, social and political consequences even when used for demographic studies or census. In addition to the very real historical conflicts associated with slavery in the Americas and various social classification systems elsewhere, such labeling has been shown by the use of ancestral identification markers to be inaccurate in many cases. Even geographic labeling, such as East Asians, ignores the marked heterogeneity of East Asians. The use of race alone to determine selection of initial antihypertensive therapy is a very limited approach. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents has demonstrated, however, that the use of age and race together may be a useful paradigm for predicting response to a single antihypertensive drug. Furthermore, individuals from populations who consume high levels of sodium and lower levels of potassium may respond better to diuretics and calcium antagonists. Other populations may be more susceptible to angioedema or cough related to the use of angiotensin-converting enzyme inhibitors. Such information may be useful for the selection or avoidance of certain medications. No patient should ever be denied indicated treatment with a drug or drug class because of race or ethnicity.

KW - African-American

KW - ancestry-informative markers

KW - blood pressure

KW - Hispanic

UR - http://www.scopus.com/inward/record.url?scp=70349774567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349774567&partnerID=8YFLogxK

U2 - 10.1016/j.jash.2009.08.001

DO - 10.1016/j.jash.2009.08.001

M3 - Article

C2 - 20409972

AN - SCOPUS:70349774567

VL - 3

SP - 291

EP - 294

JO - Journal of the American Society of Hypertension

JF - Journal of the American Society of Hypertension

SN - 1933-1711

IS - 5

ER -